RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      침샘 선양낭성암종의 세포학적, 분자생물학적 특성에 관한 연구 = CELLULAR AND MOLECULAR CHARACTERIZATION OF ADENOID CYSTIC CARCINOMA OF THE SALIVARY GLANDS

      한글로보기

      https://www.riss.kr/link?id=A105667458

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Adenoid cystic carcinoma (ACC) of salivary glands has a protracted clinical course with perineural invasion, delayed onset of hematogenous metastasis, and poor responses to classical cytotoxic chemotherapic agents. Most deaths from salivary ACC are caused by lung metastases that are resistant to conventional therapy. Therefore, knowledge of cellular properties and tumor-host interactions that influence the dissemination of metastatic cells is important for the design of more effective therapy of salivary cancer. I determined in vitro expression of epidermal growth factor receptor (EGFR) and its downstream effectors and vascular endothelial growth factor receptor (VEGFR)-2 on a human salivary ACC cell line (ACC2). I also evaluated the expression of EGF and VEGF signaling molecules and metastasis-related proteins on human salivary ACC cells orthotopically growing in nude mice. In Western blot and immunohistochemical analyses, EGFR and VEGFR-2 were presented and phosphorylated in ACC2 cells. In human parotid cancer xenografts in nude mice, EGF and VEGF signaling molecules, IL-8, and MMP-9 were expressed at markedly higher levels than in normal parotid tissues. Moreover, tumor-associated endothelial cells of this orthotopic parotid tumor expressed phosphorylated VEGFR-2 and phosphorylated Akt, which is a cell-survival protein. These data show that those biomarkers can be molecular targets for therapy of salivary ACC, which has a propensity for delayed lung metastasis.
      번역하기

      Adenoid cystic carcinoma (ACC) of salivary glands has a protracted clinical course with perineural invasion, delayed onset of hematogenous metastasis, and poor responses to classical cytotoxic chemotherapic agents. Most deaths from salivary ACC are ca...

      Adenoid cystic carcinoma (ACC) of salivary glands has a protracted clinical course with perineural invasion, delayed onset of hematogenous metastasis, and poor responses to classical cytotoxic chemotherapic agents. Most deaths from salivary ACC are caused by lung metastases that are resistant to conventional therapy. Therefore, knowledge of cellular properties and tumor-host interactions that influence the dissemination of metastatic cells is important for the design of more effective therapy of salivary cancer. I determined in vitro expression of epidermal growth factor receptor (EGFR) and its downstream effectors and vascular endothelial growth factor receptor (VEGFR)-2 on a human salivary ACC cell line (ACC2). I also evaluated the expression of EGF and VEGF signaling molecules and metastasis-related proteins on human salivary ACC cells orthotopically growing in nude mice. In Western blot and immunohistochemical analyses, EGFR and VEGFR-2 were presented and phosphorylated in ACC2 cells. In human parotid cancer xenografts in nude mice, EGF and VEGF signaling molecules, IL-8, and MMP-9 were expressed at markedly higher levels than in normal parotid tissues. Moreover, tumor-associated endothelial cells of this orthotopic parotid tumor expressed phosphorylated VEGFR-2 and phosphorylated Akt, which is a cell-survival protein. These data show that those biomarkers can be molecular targets for therapy of salivary ACC, which has a propensity for delayed lung metastasis.

      더보기

      참고문헌 (Reference)

      1 "overview of a 35 year experience with 2" 807-, 1986

      2 "overview of a 35 year experience with 2" 807-, 1986

      3 "and pharmacodynamic trial of ZD1839 in patients with five selected solid tumor types" 2002

      4 "and microvessel density in squamous cell carcinomas of the larynx Influence of microvessel density and vascular permeability factor/ vascular endothelial growth factor expression on prognosis in vulvar cancer" 19991996

      5 "Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinoma of the head and neck" Clin Cancer Res 5 : 775-82, 1999

      6 "Vascular endothelial growth factor induces endothelial fenestrations in vitro" 140 : 947-, 1998

      7 "Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade" 64 : 7977-, 2004

      8 "Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor" 1997

      9 "The many faces of metalloproteases Trends in Cell Biol 11" 2001

      10 "Suppression of epidermal growth factor receptor and Pak1 pathway and invasiveness of human cutaneous squamous cancer cells by the tyrosine kinase inhibitor ZD1839" 2003

      1 "overview of a 35 year experience with 2" 807-, 1986

      2 "overview of a 35 year experience with 2" 807-, 1986

      3 "and pharmacodynamic trial of ZD1839 in patients with five selected solid tumor types" 2002

      4 "and microvessel density in squamous cell carcinomas of the larynx Influence of microvessel density and vascular permeability factor/ vascular endothelial growth factor expression on prognosis in vulvar cancer" 19991996

      5 "Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinoma of the head and neck" Clin Cancer Res 5 : 775-82, 1999

      6 "Vascular endothelial growth factor induces endothelial fenestrations in vitro" 140 : 947-, 1998

      7 "Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade" 64 : 7977-, 2004

      8 "Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor" 1997

      9 "The many faces of metalloproteases Trends in Cell Biol 11" 2001

      10 "Suppression of epidermal growth factor receptor and Pak1 pathway and invasiveness of human cutaneous squamous cancer cells by the tyrosine kinase inhibitor ZD1839" 2003

      11 "Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis" 5 : 29-, 1986

      12 "Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck" 21 : 1980-, 2003

      13 "Paclitaxel and carboplatin for recurrent salivary gland malignancies" (5) : 3781-, 2000

      14 "Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression" 3 : 515-, 1997

      15 "Orthotopic models are necessary to predict therapy of transplantable tumors in mice" 17 : 279-, 1999

      16 "Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon carcinoma cell line" 86 : 913-, 1994

      17 "Molecular and biological properties of the vascular endothelial growth factor family of proteins" 13 : 18-, 1992

      18 "Modulation of tumor cell reponse to chemotherapy by the organ environment" 13 : 209-, 1994

      19 "Microvessel density and expression of vascular endothelial growth factor in adenoid cystic carcinoma of salivary gland" 12 : 443-, 2003

      20 "Metastatic models of human cancer xenografted in mice:the importance of orthotopic transplantation" 4-, 1994

      21 "Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Successful induction of B16-BL6 melanoma in the parotid gland of C57BL/6 black mouse Orthotopic implantaion of ACC2 cell suspension into the parotid gland A well-localized bleb confirmed a successful injection without leakage of the tumor cells The primary tumor in the parotid gland of nude mou" -200, 2000

      22 "Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Successful induction of B16-BL6 melanoma in the parotid gland of C57BL/6 black mouse Orthotopic implantaion of ACC2 cell suspension into the parotid gland A well-localized bleb confirmed a successful injection without leakage of the tumor cells The primary tumor in the parotid gland of nude mou" -200, 2000

      23 "Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells" 1 : 19-, 1995

      24 "Interleukin-8 as a macrophage derived mediator of angiogenesis" 258 : 1798-, 1992

      25 "Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin" 24 : 632-, 2002

      26 "Hypoxia-induced angiogenesis of cultured human salivary gland carcinoma cells enhances vascular endothelial growth factor production and basic fibroblast growth factor release" 37 : 77-, 2001

      27 "Extensive multi-organ metastasis following orthotopic implantation of histologically-intact human bladder carcinoma tissue in nude mice" 49 : 938-, 1991

      28 "Expression of vascular endothelial growth factor in basal cell carcinoma and cutaneous squamous cell carcinoma of the head and neck" 29 : 585-, 2002

      29 "Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis" 151 : 41-, 1997

      30 "Expression of growth factors and their receptors in invasive breast cancer Correlations with proliferation and angiogenesis" 1998

      31 "Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells:a model of glioblastoma multiforme pathophysiology" 121-, 1993

      32 "Epidermal growth factor receptors as a target for cancer treatment:the emerging role of IMC-C225 in the treatment of lung and head and neck cancers" 27-, 2002

      33 "Epidermal growth factor receptor blockade potentiates apoptosis mediated by paclitaxel and leads to prolonged survival in a murine model of oral cancer" Clin Cancer Res 9 : 3183-9, 2003

      34 "Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy" 58 : 959-, 2004

      35 "EGF receptor in neoplasia and metastasis" 12 : 255-, 1993

      36 "Chemoradiotherapy for head and neck cancer:current status and perspectives" 421-, 2004

      37 "Adenoid cystic carcinoma of the head and neck:predictors of morbidity and mortality" 149-, 1999

      38 "A decade of tyrosine kinases:from gene discovery to therapeutics" 39-, 2003

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2027 평가예정 재인증평가 신청대상 (재인증)
      2021-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2014-03-20 학술지명변경 한글명 : 대한악안면성형재건외과학회지 -> Maxillofacial Plastic Reconstructive Surgery
      외국어명 : The Journal of Korean Association of Maxillofacial Plastic and Reconstructive Surgeons -> Maxillofacial Plastic Reconstructive Surgery
      KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2003-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2002-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.23 0.23 0.18
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.12 0.09 0.443 0.1
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼